Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2022Cell ReportsOpen Access

Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacement

View Full Paper
Ask AI
Bookmark
Share

Authors

RCRaniero ChimientiVita-Salute San Raffaele UniversitySTSilvia Del TorchioVita-Salute San Raffaele UniversityFMFabio ManentiVita-Salute San Raffaele University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chimienti et al. (2022) studied this question.

synapsesocial.com/papers/6a8325d6b2f729353b1f28fahttps://doi.org/10.1016/j.celrep.2022.111423
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1NKG2D Receptor and Its Ligands in Host Defense2015 · 602 citations
  2. 2Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-12015 · 62 citations
  3. 3Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer2016 · 42 citations
  4. 4Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo2013 · 269 citations